Hisam Siddiqi: Understanding Bone Marrow Trephine Morphology in MPNs
Hisam Siddiqi, Consultant Haematologist at LycaHealth, The Blackheath Hospital, Dartford and Gravesham NHS Trust, shared a post on LinkedIn:
“Understanding Bone Marrow Trephine Morphology in MPNs – A Simple Breakdown
Myeloproliferative neoplasms (MPNs) can often look similar clinically, but the bone marrow trephine provides important clues that help us distinguish between them.
Here’s a quick, simplified guide to typical findings across the main MPN subtypes, based on key features: cellularity, megakaryocyte morphology, clustering patterns, and reticulin fibrosis.
Polycythaemia Vera (PRV)
- Cellularity: Very high (panmyelosis – all cell lines increased)
- Megakaryocytes: Mildly increased
- Clusters: Usually absent
- Reticulin: Normal or slightly up
- Think: a busy marrow with everything ‘turned up.’
Essential Thrombocythaemia (ET)
- Cellularity: Normal
- Megakaryocytes: Markedly increased, hyperlobulated (‘staghorn’)
- Clusters: None or loose
- Reticulin: Normal or slightly up
- Think: lots of large, mature megakaryocytes with big, multilobed nuclei.
Pre‑Fibrotic Myelofibrosis (pre‑MF)
- Cellularity: Increased
- Megakaryocytes: Variable up; abnormally shaped, atypical, hypolobulated
- Clusters: Small, dense or loose
- Reticulin: Mildly up
- Think: dysplastic megakaryocytes plus early scarring.
Overt Myelofibrosis (MF)
- Cellularity: Often reduced
- Megakaryocytes: Increased, hypolobulated / atypical
- Clusters: Dense, tight clusters
- Reticulin: Marked fibrosis with collagen deposition
- Think: fibrotic, scarred marrow with abnormal megakaryocyte clusters.
Why this matters:
Trephine morphology remains central to accurate MPN diagnosis and helps guide prognosis and treatment decisions. Recognising these hallmark patterns can refine our diagnostic confidence and improve patient care.”

More posts featuring Hisam Siddiqi on Hemostasis Today.
-
May 24, 2026, 17:48Flora Peyvandi: Crucial Role of Placental ADAMTS13 in Perinatal Survival
-
May 24, 2026, 17:13Mahtab Mashayekhi: The Evolving Role of Red Blood Cell Exchange in the Management of SCD
-
May 24, 2026, 17:12Silvina Graña: Helping Families Better Understand Hemophilia and Daily Life With Bleeding Disorders
-
May 24, 2026, 17:11Miikka Vikkula: Key Insights from the ISSVA 2026 World Congress
-
May 24, 2026, 17:10Mathieu Jackson: Proud to Be Present at This Historic Moment for the Global Bleeding Disorders Community
-
May 24, 2026, 17:09Ramina Fazeli: Highlighting the Emerging Role of Neutrophil Extracellular Traps in Ovarian Cancer
-
May 24, 2026, 16:12William Wallace: Normal B12 Levels May Still Cause Brain Damage and Cognitive Decline
-
May 24, 2026, 15:54Marc Carrier: Ottawa Race Weekend Raised Over 7,000 USD for Thrombosis Canada
-
May 24, 2026, 15:44Janak Sadhu: Building a Stroke-Free Mehsana Through Community Awareness and Healthcare Collaboration